InvestorsHub Logo
Followers 22
Posts 996
Boards Moderated 0
Alias Born 08/01/2016

Re: None

Tuesday, 10/18/2016 10:04:12 PM

Tuesday, October 18, 2016 10:04:12 PM

Post# of 462424
A Biogen possibility : BIIB could have suggested the data collection firm to verify these amazing results in Alzheimers so they can make a substantial offer and verify the cost to shareholders and reinstate a leadership role in ALZ treatment. Bonus would also be to acquire this safe medicine that crosses the brain barrier and seems to work in many CNS diseases better than current treatments.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News